Vitamin D Pilot Study in Patients With Multiple Sclerosis

University of Wisconsin (UW)

Status and phase: Completed; Phase 1

Conditions: Relapsing Remitting Multiple Sclerosis

Treatments: Drug: 19 nor vitamin d

Study type: Interventional

Funder types: Other

Identifiers

NCT01257958

HSC #97-676-311

Details and patient eligibility

About

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• relapsing remitting MS

Exclusion criteria

• MRI contraindicated

Trial design

0 participants in 1 patient group

19 nor vitamin d

Experimental group

Treatment:

Drug: 19 nor vitamin d